StockData
Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc. (KPTIQ) revenue by segment

KPTIQOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
Share price
Not available yet

Price, market cap and P/E appear here once daily prices are connected.

Karyopharm Therapeutics Inc. revenue by segment

By business segment

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017% of revenueYoY
Product$114.86M$112.81M$112.01M$120.45M$98.44M$76.21M$30.54M$0–78.6%+1.8%
License and Other$31.21M$32.43M$34.02M$36.63M$111.38M$31.88M$10.35M$30.34M$1.61M21.4%-3.8%

By region

From the segment and revenue-disaggregation notes of Karyopharm Therapeutics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes. The KPIs tab shows these segments next to Karyopharm Therapeutics's operating metrics, with full history, charts and a link to each filing.

See a number that looks wrong?